Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer
Identifieur interne : 000893 ( France/Analysis ); précédent : 000892; suivant : 000894Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer
Auteurs : Emmanuel Touboul [France] ; Laurent Buffat [France] ; Jean-Pierre Lefranc [France] ; Jean Blondon [France] ; Elisabeth Deniaud [France] ; Hamid Mammar [France] ; Alain Laugier [France] ; Michel Schlienger [France]Source :
- International Journal of Radiation Oncology, Biology, Physics [ 0360-3016 ] ; 1996.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Association thérapeutique, Carcinome canalaire du sein (), Carcinome lobulaire (), Facteurs temps, Femelle, Humains, Induction de rémission, Maladie résiduelle, Métastase lymphatique, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Récidive tumorale locale, Stade de la tumeur, Sujet âgé, Taux de survie, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (radiothérapie), Tumeurs du sein (traitement médicamenteux), Échec thérapeutique, Études de suivi, Études prospectives.
- MESH :
- anatomopathologie : Tumeurs du sein.
- effets indésirables : Protocoles de polychimiothérapie antinéoplasique.
- radiothérapie : Tumeurs du sein.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- Adulte, Adulte d'âge moyen, Association thérapeutique, Carcinome canalaire du sein, Carcinome lobulaire, Facteurs temps, Femelle, Humains, Induction de rémission, Maladie résiduelle, Métastase lymphatique, Récidive tumorale locale, Stade de la tumeur, Sujet âgé, Taux de survie, Tumeurs du sein, Échec thérapeutique, Études de suivi, Études prospectives.
English descriptors
- KwdEn :
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Breast Neoplasms (drug therapy), Breast Neoplasms (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Breast Neoplasms (therapy), Carcinoma, Ductal, Breast (therapy), Carcinoma, Lobular (therapy), Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Neoplasm, Residual, Prospective Studies, Remission Induction, Survival Rate, Time Factors, Treatment Failure.
- MESH :
- adverse effects : Antineoplastic Combined Chemotherapy Protocols.
- drug therapy : Breast Neoplasms.
- pathology : Breast Neoplasms.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular.
- Adult, Aged, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Neoplasm, Residual, Prospective Studies, Remission Induction, Survival Rate, Time Factors, Treatment Failure.
Url:
DOI: 10.1016/0360-3016(95)02207-4
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004485
- to stream Istex, to step Curation: 004485
- to stream Istex, to step Checkpoint: 004192
- to stream Main, to step Merge: 00C651
- to stream PubMed, to step Corpus: 005201
- to stream PubMed, to step Curation: 005201
- to stream PubMed, to step Checkpoint: 005201
- to stream Ncbi, to step Merge: 00B679
- to stream Ncbi, to step Curation: 00B679
- to stream Ncbi, to step Checkpoint: 00B679
- to stream Main, to step Merge: 00C504
- to stream Main, to step Curation: 00BD98
- to stream Main, to step Exploration: 00BD98
- to stream France, to step Extraction: 000893
Links to Exploration step
ISTEX:91DB980A4CE23545FBFF812CBCD3DDB3987C1666Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer</title><author><name sortKey="Touboul, Emmanuel" sort="Touboul, Emmanuel" uniqKey="Touboul E" first="Emmanuel" last="Touboul">Emmanuel Touboul</name></author><author><name sortKey="Buffat, Laurent" sort="Buffat, Laurent" uniqKey="Buffat L" first="Laurent" last="Buffat">Laurent Buffat</name></author><author><name sortKey="Lefranc, Jean Pierre" sort="Lefranc, Jean Pierre" uniqKey="Lefranc J" first="Jean-Pierre" last="Lefranc">Jean-Pierre Lefranc</name></author><author><name sortKey="Blondon, Jean" sort="Blondon, Jean" uniqKey="Blondon J" first="Jean" last="Blondon">Jean Blondon</name></author><author><name sortKey="Deniaud, Elisabeth" sort="Deniaud, Elisabeth" uniqKey="Deniaud E" first="Elisabeth" last="Deniaud">Elisabeth Deniaud</name></author><author><name sortKey="Mammar, Hamid" sort="Mammar, Hamid" uniqKey="Mammar H" first="Hamid" last="Mammar">Hamid Mammar</name></author><author><name sortKey="Laugier, Alain" sort="Laugier, Alain" uniqKey="Laugier A" first="Alain" last="Laugier">Alain Laugier</name></author><author><name sortKey="Schlienger, Michel" sort="Schlienger, Michel" uniqKey="Schlienger M" first="Michel" last="Schlienger">Michel Schlienger</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:91DB980A4CE23545FBFF812CBCD3DDB3987C1666</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1016/0360-3016(95)02207-4</idno><idno type="url">https://api.istex.fr/document/91DB980A4CE23545FBFF812CBCD3DDB3987C1666/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004485</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004485</idno><idno type="wicri:Area/Istex/Curation">004485</idno><idno type="wicri:Area/Istex/Checkpoint">004192</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">004192</idno><idno type="wicri:doubleKey">0360-3016:1996:Touboul E:possibility:of:conservative</idno><idno type="wicri:Area/Main/Merge">00C651</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:8600084</idno><idno type="wicri:Area/PubMed/Corpus">005201</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005201</idno><idno type="wicri:Area/PubMed/Curation">005201</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005201</idno><idno type="wicri:Area/PubMed/Checkpoint">005201</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005201</idno><idno type="wicri:Area/Ncbi/Merge">00B679</idno><idno type="wicri:Area/Ncbi/Curation">00B679</idno><idno type="wicri:Area/Ncbi/Checkpoint">00B679</idno><idno type="wicri:doubleKey">0360-3016:1996:Touboul E:possibility:of:conservative</idno><idno type="wicri:Area/Main/Merge">00C504</idno><idno type="wicri:Area/Main/Curation">00BD98</idno><idno type="wicri:Area/Main/Exploration">00BD98</idno><idno type="wicri:Area/France/Extraction">000893</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer</title><author><name sortKey="Touboul, Emmanuel" sort="Touboul, Emmanuel" uniqKey="Touboul E" first="Emmanuel" last="Touboul">Emmanuel Touboul</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Cancérologie-Radiothérapie, Hôpital Tenon, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Buffat, Laurent" sort="Buffat, Laurent" uniqKey="Buffat L" first="Laurent" last="Buffat">Laurent Buffat</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Unité de Statistique et d'Informatique, Hôpital Tenon, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lefranc, Jean Pierre" sort="Lefranc, Jean Pierre" uniqKey="Lefranc J" first="Jean-Pierre" last="Lefranc">Jean-Pierre Lefranc</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Chirurgie Gynécologique, Hôpital Pitié-Salpêtrière, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Blondon, Jean" sort="Blondon, Jean" uniqKey="Blondon J" first="Jean" last="Blondon">Jean Blondon</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Chirurgie Gynécologique, Hôpital Pitié-Salpêtrière, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Deniaud, Elisabeth" sort="Deniaud, Elisabeth" uniqKey="Deniaud E" first="Elisabeth" last="Deniaud">Elisabeth Deniaud</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Cancérologie-Radiothérapie, Hôpital Tenon, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Mammar, Hamid" sort="Mammar, Hamid" uniqKey="Mammar H" first="Hamid" last="Mammar">Hamid Mammar</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Cancérologie-Radiothérapie, Hôpital Tenon, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Laugier, Alain" sort="Laugier, Alain" uniqKey="Laugier A" first="Alain" last="Laugier">Alain Laugier</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Cancérologie-Radiothérapie, Hôpital Tenon, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Schlienger, Michel" sort="Schlienger, Michel" uniqKey="Schlienger M" first="Michel" last="Schlienger">Michel Schlienger</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Service de Cancérologie-Radiothérapie, Hôpital Tenon, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">International Journal of Radiation Oncology, Biology, Physics</title><title level="j" type="abbrev">ROB</title><idno type="ISSN">0360-3016</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1996">1996</date><biblScope unit="volume">34</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1019">1019</biblScope><biblScope unit="page" to="1028">1028</biblScope></imprint><idno type="ISSN">0360-3016</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0360-3016</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (radiotherapy)</term><term>Breast Neoplasms (surgery)</term><term>Breast Neoplasms (therapy)</term><term>Carcinoma, Ductal, Breast (therapy)</term><term>Carcinoma, Lobular (therapy)</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Neoplasm Staging</term><term>Neoplasm, Residual</term><term>Prospective Studies</term><term>Remission Induction</term><term>Survival Rate</term><term>Time Factors</term><term>Treatment Failure</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Carcinome canalaire du sein ()</term><term>Carcinome lobulaire ()</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Induction de rémission</term><term>Maladie résiduelle</term><term>Métastase lymphatique</term><term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term><term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term><term>Récidive tumorale locale</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (radiothérapie)</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Échec thérapeutique</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term><term>Carcinoma, Lobular</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Neoplasm Staging</term><term>Neoplasm, Residual</term><term>Prospective Studies</term><term>Remission Induction</term><term>Survival Rate</term><term>Time Factors</term><term>Treatment Failure</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Carcinome canalaire du sein</term><term>Carcinome lobulaire</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Induction de rémission</term><term>Maladie résiduelle</term><term>Métastase lymphatique</term><term>Récidive tumorale locale</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tumeurs du sein</term><term>Échec thérapeutique</term><term>Études de suivi</term><term>Études prospectives</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Touboul, Emmanuel" sort="Touboul, Emmanuel" uniqKey="Touboul E" first="Emmanuel" last="Touboul">Emmanuel Touboul</name></region><name sortKey="Blondon, Jean" sort="Blondon, Jean" uniqKey="Blondon J" first="Jean" last="Blondon">Jean Blondon</name><name sortKey="Buffat, Laurent" sort="Buffat, Laurent" uniqKey="Buffat L" first="Laurent" last="Buffat">Laurent Buffat</name><name sortKey="Deniaud, Elisabeth" sort="Deniaud, Elisabeth" uniqKey="Deniaud E" first="Elisabeth" last="Deniaud">Elisabeth Deniaud</name><name sortKey="Laugier, Alain" sort="Laugier, Alain" uniqKey="Laugier A" first="Alain" last="Laugier">Alain Laugier</name><name sortKey="Lefranc, Jean Pierre" sort="Lefranc, Jean Pierre" uniqKey="Lefranc J" first="Jean-Pierre" last="Lefranc">Jean-Pierre Lefranc</name><name sortKey="Mammar, Hamid" sort="Mammar, Hamid" uniqKey="Mammar H" first="Hamid" last="Mammar">Hamid Mammar</name><name sortKey="Schlienger, Michel" sort="Schlienger, Michel" uniqKey="Schlienger M" first="Michel" last="Schlienger">Michel Schlienger</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000893 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000893 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:91DB980A4CE23545FBFF812CBCD3DDB3987C1666
|texte= Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer
}}
| This area was generated with Dilib version V0.6.31. |  |